Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Promoter methylation in HNSCC tumor cell lines is significantly different from primary tumors and xenografts

ABSTRACT: This study focused on global methylation changes between tumors, normal mucosa, primary tumor xenografts, and cell lines in order to determine epigenetic changes in cell cultures and xenografts derived from primary tumors.

ORGANISM(S): Homo sapiens

PROVIDER: GSE24787 | GEO | 2011/10/01

SECONDARY ACCESSION(S): PRJNA132239

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Promoter methylation in HNSCC tumor cell lines is significantly different from primary tumors and xenografts

Project description:This study focused on global methylation changes between tumors, normal mucosa, primary tumor xenografts, and cell lines in order to determine epigenetic changes in cell cultures and xenografts derived from primary tumors. 1 fully methylated control cell line, 1 fully demethylated control cell line, 5 HNSCC cell lines, 2 normal cell lines, 7 normal mucosa, 3 primary HNSCC tumors, 3 xenografts of primary tumors

2011-09-30 | E-GEOD-24787 | biostudies-arrayexpress

Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

Project description:Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

| PRJNA478618 | ENA

Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

Project description:Regulatory Changes in Glioblastoma Brain Tumors and Xenografts

| PRJNA478619 | ENA

Molecular variability of patient-derived colon tumor xenografts

Project description:Primary tumors and their corresponding P2 mouse xenografts were surveyed for gene expression using the RNA-sequencing approach.

2018-12-19 | GSE112941 | GEO

Patient-derived Human Breast Cancer Xenografts

Project description:Breast cancer research is hampered by difficulties in obtaining and studying primary human breast tissue, and by the lack of in vivo preclinical models that reflect patient tumor biology accurately. To overcome these limitations, we propagated a cohort of human breast tumors grown in the epithelium-free mammary fat pad of SCID/Beige and NOD/SCID/IL2γ-receptor null (NSG) mice, under a series of transplant conditions. Both models yielded stably transplantable xenografts at comparably high rates (~23% and ~19%, respectively). Of the conditions tested, xenograft take rate was highest in the presence of a low-dose estradiol pellet. Overall, 32 stably transplantable xenograft lines were established, representing unique 25 patients. Most tumors yielding xenografts were “triple-negative” (ER-PR-HER2+) (n=19). However, we established lines from three ER-PR-HER2+ tumors, one ER+PR-HER2-, one ER+PR+HER2- and one “triple-positive” (ER+PR+HER2+) tumor. Serially passaged xenografts show biological consistency with the tumor of origin, are phenotypic stability across multiple transplant generations at the histological, transcriptomic, proteomic, and genomic levels, and show comparable treatment responses. Xenografts representing 12 patients, including two ER+ lines, showed metastasis to the mouse lung. These models thus serve as a renewable, quality-controlled tissue resource for preclinical studies investigating treatment response and metastasis. The study was designed to determine how stable patient-derived xenografts are across multiple transplant generations in mice, and to determine how closely xenografts established with pre-treatment samples cluster with xenografts established with post-treatment samples. Overall, pre-treatment and post-treatment samples derived from the same patient cluster together, and multiple transplant generations of xenografts derived from an individual patient cluster together.

2013-05-30 | E-GEOD-46106 | biostudies-arrayexpress

Patient-derived Human Breast Cancer Xenografts

2013-05-30 | GSE46106 | GEO

Transcription profiling of human primarylung cancer tumors and their SCID mouse xenografts

Project description:MicroRNA expression in eight human non-small cell lung carcinoma xenografts grown in SCID mice was compared with the primary human tumors. Formalin-fixed and paraffin-embedded tissue specimens were used.

2009-06-30 | E-TABM-720 | biostudies-arrayexpress

Expression data from patient and primary xenografts esophageal tumour samples

Project description:Microarrays were used to assess differences between 1) human tumours that did and did not engraft, 2) human tumours and their matched primary xenografts, 3) early and late passage primary xenografts and 4) small and large primary xenografts for a series of esophageal patient and primary xenograft tumours

2015-01-11 | GSE58870 | GEO

RNA-seq of prostate cancer Patient‐Derived Xenografts derived from primary and metastatic tumors at different stages of progression

Project description:Patient-Derived Xenografts from primary (PNPCa) and metastatic (LuCaP series) prostate tumors have been implanted in immunocompromised mice and then subjected to PolyA+ RNA-sequencing.

2020-12-10 | E-MTAB-9656 | biostudies-arrayexpress

Estrogen receptor dynamics in diverse patient-derived luminal breast cancer xenografts

Project description:Primary breast cancer xenografts Two primary xenografts with different treatments

2013-02-24 | E-GEOD-36075 | biostudies-arrayexpress